Tag: Implanet
Implanet: Turnover up slightly in the first quarter
(CercleFinance.com) – Implanet, a manufacturer of implants intended for orthopedic surgery, reported yesterday evening a turnover up slightly by 1% for its first quarter, to €2.22 million. ‘euros. In a…
Implanet: 1% increase in quarterly turnover
(AOF) – Implanet revealed turnover for its first quarter up 1% to 2.22 million euros. The medtech specializing in implants intended for orthopedic surgery and in the distribution of technological…
Implanet announces the success of its capital increase – 02/02/2024 at 6:00 p.m.
o Fund raising of €5.5 million through the issue of 83,924,897 new shares o Sanyou (HK) International Medical Holding Co., limited strengthens its participation and holds 74.56% of the capital…
Implanet: success of the capital increase of 5.5 million euros – 02/02/2024 at 6:27 p.m.
(AOF) – Implanet announces the success of the capital increase in cash with maintenance of shareholders’ preferential subscription rights announced on January 4, 2024. The medtech specialist in spinal implants…
Implanet: success of the capital increase of 5.5 million euros
(AOF) – Implanet announces the success of the capital increase in cash with maintenance of shareholders’ preferential subscription rights announced on January 4, 2024. The medtech specialist in spinal implants…
Implanet: Max W. Painter (ex-Nuvasive) will lead the American subsidiary
(AOF) – Implanet announces the appointment of Max W. Painter to the position of vice president and general manager of Implanet America. The medtech specialist in implants intended for orthopedic…
Implanet: annual turnover down 7%, fundraising in sight
(AOF) – Implanet announced a turnover down 20% in the fourth quarter, to 1.64 million euros, and an annual turnover for 2023 down 10% to 7.44 million euros. euros. The…
Implanet: annual turnover down 7%, fundraising in sight – 01/15/2024 at 6:27 p.m.
(AOF) – Implanet announced a turnover down 20% in the fourth quarter, to 1.64 million euros, and an annual turnover for 2023 down 10% to 7.44 million euros. euros. The…
Implanet: 2024 financial agenda
By Alexandra Saintpierre Published on 01/11/2024 at 5:42 p.m. (Boursier.com) — The Bordeaux company Implanet announces its financial…
Implanet: capital increase in cash – 01/05/2024 at 08:41
(AOF) – Implanet, a medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces the launch of a cash capital increase…
Implanet: capital increase in cash
(AOF) – Implanet, a medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces the launch of a cash capital increase…
Implanet entrusts its Listing Sponsor contract to the company Atout Capital
(AOF) – Implanet, a medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces that it has entrusted its Listing Sponsor…